Target Name: NCAM2
NCBI ID: G4685
Review Report on NCAM2 Target / Biomarker Content of Review Report on NCAM2 Target / Biomarker
NCAM2
Other Name(s): Neural cell adhesion molecule 2 (NCAM2) | Neural cell adhesion molecule 2 (isoform 2) | N-CAM-2 | NCAM21 | neural cell adhesion molecule 2 | Neural cell adhesion molecule 2 | NCAM 2 | OTTHUMP00000095814 | Neural cell adhesion molecule 2, transcript variant 2 | MGC51008 | NCAM2 variant 2 | NCAM2_HUMAN | NCAM-2

Understanding NCAM2: A Potential Drug Target for Neurological Disorders

Neural cell adhesion molecule 2 (NCAM2) is a protein that is expressed in the nervous system and plays a crucial role in the development and maintenance of neural tissues. It is a member of the immunoglobulin superfamily and is expressed in a variety of tissues, including brain, spinal cord, and peripheral tissues. NCAM2 is involved in several cellular processes that are critical for normal function of the nervous system, including cell adhesion, migration, and survival.

One of the key functions of NCAM2 is its role in cell adhesion. NCAM2 is a critical adhesion molecule that is involved in the formation of tight junctions, which are the structural bonds that connect adjacent cells in neural tissues. tight junctions are essential for maintaining the integrity of the nervous system and for ensuring the proper communication between cells.

NCAM2 is also involved in the regulation of cell migration. During the development of neural tissues, NCAM2 plays a critical role in the migration of neurons and other cells to their final destinations. This is important for the formation of neural tissues and for the development of normal neural circuits.

In addition to its role in cell adhesion and migration, NCAM2 is also involved in the regulation of cell survival. Neurons are highly sensitive to environmental changes and must be able to respond quickly to changes in their environment in order to survive. NCAM2 plays a critical role in this process by helping to regulate the production of pro-inflammatory molecules that can cause damage to neurons.

NCAM2 is also involved in several other cellular processes that are important for neural tissue development and maintenance. For example, it is involved in the regulation of cell proliferation, differentiation, and angiogenesis. Additionally, NCAM2 is involved in the regulation of neurotransmitter release and in the modulation of pain perception.

Given its involvement in so many critical cellular processes, NCAM2 is a potential drug target and may be useful for the treatment of a variety of neurological and psychiatric disorders. For example, some studies have suggested that NCAM2 may be a potential therapeutic target for the treatment of Alzheimer's disease, depression, and other psychiatric disorders.

In conclusion, NCAM2 is a protein that is involved in a variety of critical cellular processes in the nervous system. Its role in cell adhesion, migration, and survival makes it a potential drug target and a promising biomarker for the treatment of a variety of neurological diseases and psychiatric disorders. Further research is needed to fully understand the mechanisms of NCAM2's function and to develop effective treatments based on its potential as a drug target.

Protein Name: Neural Cell Adhesion Molecule 2

Functions: May play important roles in selective fasciculation and zone-to-zone projection of the primary olfactory axons

The "NCAM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCAM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NCAN | NCAPD2 | NCAPD3 | NCAPG | NCAPG2 | NCAPH | NCAPH2 | NCBP1 | NCBP2 | NCBP2-AS1 | NCBP2AS2 | NCBP3 | NCCRP1 | NCDN | NCEH1 | NCF1 | NCF1B | NCF1C | NCF2 | NCF4 | NCF4-AS1 | NCK1 | NCK1-DT | NCK2 | NCKAP1 | NCKAP1L | NCKAP5 | NCKAP5-AS2 | NCKAP5L | NCKIPSD | NCL | NCLN | NCMAP | NCMAP-DT | NCOA1 | NCOA2 | NCOA3 | NCOA4 | NCOA5 | NCOA6 | NCOA7 | NCOR1 | NCOR1P1 | NCOR2 | NCR1 | NCR2 | NCR3 | NCR3LG1 | NCRUPAR | NCS1 | NCSTN | ND1 | ND2 | ND3 | ND4 | ND4L | ND5 | ND6 | NDC1 | NDC80 | NDC80 kinetochore complex | NDE1 | NDEL1 | NDFIP1 | NDFIP2 | NDN | NDNF | NDOR1 | NDP | NDRG1 | NDRG2 | NDRG3 | NDRG4 | NDST1 | NDST1-AS1 | NDST2 | NDST3 | NDST4 | NDUFA1 | NDUFA10 | NDUFA11 | NDUFA12 | NDUFA13 | NDUFA2 | NDUFA3 | NDUFA3P3 | NDUFA4 | NDUFA4L2 | NDUFA5 | NDUFA5P11 | NDUFA6 | NDUFA6-DT | NDUFA7 | NDUFA8 | NDUFA9 | NDUFAB1 | NDUFAF1 | NDUFAF2 | NDUFAF3 | NDUFAF4